{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$3.09 vs. cons $3.04",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Worldwide constant-dollar RevPAR growth",
      "prediction": "BEAT",
      "answer": "pred ~2.4% vs. cons 2.1%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Gross fee revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.555B vs. cons $1.548B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 worldwide constant-dollar RevPAR growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~2.5% vs. cons 2.5% (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted EBITDA",
      "prediction": "UNCHANGED",
      "answer": "guide ~$5.93B vs. cons $5.94B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted diluted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$11.55 vs. cons $11.54 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 net rooms growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~4.75% vs. cons 4.75% (FY26)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.25,
  "day5_path": "STABILIZE",
  "day5_rationale": "A modest EPS and RevPAR beat should support an initial positive reaction, but maintained FY26 RevPAR, EBITDA, and EPS outlooks imply little upward out-period estimate math; the stock should retain most of the gain rather than materially extend it.",
  "day5_confidence": "MEDIUM"
}